Thomas O’Hare

10.7k citations
133 papers · 8.8k · 4 hit papers · h-index 43

Impact in

  • Hematology top 0.1%
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research
  • Genetics top 0.1%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Chronic Myeloid Leukemia Treatments 100
    • Acute Myeloid Leukemia Research 17
    • Chronic Lymphocytic Leukemia Research 80
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 18

Thomas O’Hare

131 papers receiving 8.6k citations

Thomas O’Hare's Hit Papers

Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias 2012 · 622 citations
6220+7+14Years since publication2505007501000

Peers

Thomas O’Hare
Comparison fields: 5 of 118
  • Hematology 5.8k
  • Genetics 4.1k
  • Rheumatology 2.1k
  • Oncology 1.4k
  • Molecular Biology 2.3k
Replace Junia V. Melo with:
Junia V. Melo United Kingdom
Mercedes E. Gorre United States
Philippe H. Rousselot France
Javier Pinilla-Ibarz United States
Johan Richter Sweden
Steffen Koschmieder Germany
Brian J.P. Huntly United Kingdom
Ilaria Iacobucci Italy
Ali G. Turhan France
Juerg Schwaller Switzerland
Thomas O’Hare relative to Junia V. Melo United Kingdom Junia V. Melo's profile →
Citations per field
00.5×1.5×2.0×
Junia V. Melo · 1×
Citations per year

Countries citing papers authored by Thomas O’Hare

Since Specialization
Citations

This map shows the geographic impact of Thomas O’Hare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas O’Hare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas O’Hare more than expected).

Fields of papers citing papers by Thomas O’Hare

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas O’Hare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas O’Hare. The network helps show where Thomas O’Hare may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas O’Hare, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas O’Hare Line = papers co-authored together Thomas O’Hare links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 133 papers — load more, or switch the sort, to bring in the rest.

#Work
1
AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
Hit paper breakdown →
20091045
2
In vitro Activity of Bcr-Abl Inhibitors AMN107 and BMS-354825 against Clinically Relevant Imatinib-Resistant Abl Kinase Domain Mutants
Hit paper breakdown →
2005888
3
Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
Hit paper breakdown →
2012622
4
Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia
Hit paper breakdown →
2007527
5 2006348
6 2014293
7 2006278
8 2012259
9 2011242
10 2012185
11 2019184
12 2006171
13 2004170
14 2017164
15 2005150
16 2015149
17 2010149
18 2012123
19 2010118
20 2014117

About Thomas O’Hare

Thomas O’Hare is a scholar working on Hematology, Genetics, Rheumatology, Public Health, Environmental and Occupational Health and Oncology, having authored 133 papers that have together received 8.8k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (100 papers), Chronic Lymphocytic Leukemia Research (80 papers), Eosinophilic Disorders and Syndromes (47 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers), Acute Myeloid Leukemia Research (17 papers), Acute Lymphoblastic Leukemia research (13 papers), Click Chemistry and Applications (6 papers) and Quinazolinone synthesis and applications (6 papers). The work is most often cited by research in Hematology (5.8k citations), Genetics (4.1k citations), Rheumatology (2.1k citations), Oncology (1.4k citations) and Molecular Biology (2.3k citations). Thomas O’Hare has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Michael W. Deininger, Brian J. Druker, Christopher A. Eide, Francis Y. Lee, Denise K. Walters, Eric P. Stoffregen, Matthew S. Zabriskie, Michael Charles Heinrich, Anna M. Eiring and Amie S. Corbin. Their work appears in journals such as Blood, Leukemia, Cancer Research, Cancer Cell and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact